<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jacob V</submitter><funding>Intramural CDC HHS</funding><pagination>e202-e222</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8863641</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(3)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Adherence to medications for cardiovascular disease and its risk factors is less than optimal, although greater adherence to medication has been shown to reduce the risk factors for cardiovascular disease. This paper examines the economics of tailored pharmacy interventions to improve medication adherence for cardiovascular disease prevention and management.&lt;h4>Methods&lt;/h4>Literature from inception of databases to May 2019 was searched, yielding 29 studies for cardiovascular disease prevention and 9 studies for cardiovascular disease management. Analyses were done from June 2019 through May 2020. All monetary values are in 2019 U.S. dollars.&lt;h4>Results&lt;/h4>The median intervention cost per patient per year was $246 for cardiovascular disease prevention and $292 for card</pubmed_abstract><journal>American journal of preventive medicine</journal><pubmed_title>Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.</pubmed_title><pmcid>PMC8863641</pmcid><funding_grant_id>CC999999</funding_grant_id><pubmed_authors>Hopkins DP</pubmed_authors><pubmed_authors>Rask KJ</pubmed_authors><pubmed_authors>Clymer JM</pubmed_authors><pubmed_authors>Kottke TE</pubmed_authors><pubmed_authors>Community Preventive Services Task Force (CPSTF)</pubmed_authors><pubmed_authors>Therrien NL</pubmed_authors><pubmed_authors>Durthaler JM</pubmed_authors><pubmed_authors>Chattopadhyay SK</pubmed_authors><pubmed_authors>Jones CD</pubmed_authors><pubmed_authors>Reynolds JA</pubmed_authors><pubmed_authors>Cuellar AE</pubmed_authors><pubmed_authors>Jacob V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.</name><description>&lt;h4>Introduction&lt;/h4>Adherence to medications for cardiovascular disease and its risk factors is less than optimal, although greater adherence to medication has been shown to reduce the risk factors for cardiovascular disease. This paper examines the economics of tailored pharmacy interventions to improve medication adherence for cardiovascular disease prevention and management.&lt;h4>Methods&lt;/h4>Literature from inception of databases to May 2019 was searched, yielding 29 studies for cardiovascular disease prevention and 9 studies for cardiovascular disease management. Analyses were done from June 2019 through May 2020. All monetary values are in 2019 U.S. dollars.&lt;h4>Results&lt;/h4>The median intervention cost per patient per year was $246 for cardiovascular disease prevention and $292 for card</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T21:43:45.66Z</modification><creation>2025-04-04T21:43:45.66Z</creation></dates><accession>S-EPMC8863641</accession><cross_references><pubmed>34876318</pubmed><doi>10.1016/j.amepre.2021.08.021</doi></cross_references></HashMap>